title: A randomized trial comparing the effect of ramipril and losartan in survivors of ST-elevation myocardial infarction.
abstract: This study investigated the effect of 8 weeks of treatment with ramipril or losartan on N-terminal pro-brain natriuretic peptide (NT-proBNP) plasma levels, plasminogen activator inhibitor-1 (PAI-1) activity, echocardiographic parameters and lipid profiles in patients after acute myocardial infarction (MI). Patients were randomly assigned to receive up to 10 mg/day ramipril (n = 27) or up to 100 mg/day losartan (n = 26). No significant differences in any of the tested variables were observed between the two treatment groups, either before or after treatment. Within the losartan-treated group a significant decrease in levels of NT-proBNP (211.1 +/- 211.5 versus 94.7 +/- 150.1 pg/ml), total cholesterol (5.7 +/- 1.0 versus 4.6 +/- 1.1 mmol/l), and low-density lipoprotein-cholesterol (3.5 +/- 0.9 versus 2.7 +/- 1.0 mmol/l) was observed after treatment compared with baseline. Thus, after an acute MI, losartan seems equal to ramipril in terms of the NT-proBNP levels, echocardiographic parameters, PAI-1 activity and lipid profiles that were achieved.
authors.affiliation: Department of Medical Intensive Care, University Clinical Centre Maribor, Maribor, Slovenia.
authors.forename: M
authors.initials: M
authors.lastname: Marinsek
authors.forename: Andreja
authors.initials: A
authors.lastname: Sinkovic
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010446:Peptide Fragments / Q000097:blood; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D011379:Prognosis; D011446:Prospective Studies; D017257:Ramipril / Q000627:therapeutic use*; D017741:Survivors; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D010446:Peptide Fragments; D017395:Plasminogen Activator Inhibitor 1; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain; D019808:Losartan; D017257:Ramipril